Elez Fernandez, M. E., Ros Montañá, F. J., Fernández, J., Moreno-Cárdenas, A. B., Arenillas Lallana, C., Fasani, R., . . . Piris-Giménez, A. (2022). RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer.
Citación estilo ChicagoElez Fernandez, Mª Elena, et al. RNF43 Mutations Predict Response to Anti-BRAF/EGFR Combinatory Therapies in BRAFV600E Metastatic Colorectal Cancer. 2022.
Cita MLAElez Fernandez, Mª Elena, et al. RNF43 Mutations Predict Response to Anti-BRAF/EGFR Combinatory Therapies in BRAFV600E Metastatic Colorectal Cancer. 2022.
Precaución: Estas citas no son 100% exactas.